MedPath

A prospective, multi-centre randomised comparative study ofimplant fit, clinical outcomes and satisfaction with the Stryker Accolade II Hip Stem compared to the Corail Hip Stem

Phase 4
Completed
Conditions
Total Hip Replacement Surgery
Non-Inflammatory Degenerative Joint Disease of the Hip
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12613000629730
Lead Sponsor
Stryker Australia Pty Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
304
Inclusion Criteria

1.Patient are male or non-pregnant females requiring a cementless THR for non-inflammatory degenerative joint disease of the hip.
2.Must be older than 18 years

Exclusion Criteria

1. Patient has a cognitive impairment, an intellectual disability or a mental illness
2. People whose primary language is other than English
3. Pregnant Women
4. Children and or/young people (ie. <18 years)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To compare the pre-operative plan with the intraoperative size preferance of femoral stem in patients randomised to either Accolade II or Corail femoral stem. <br>Radiolographs and surgical data[Pre-Operative, Intra-Operative];2. To determine clinical outcomes of THR, using the Oxford Hip Score, in patients receiving the Accolade II femoral stem compared to Corail femoral stem<br>[Pre-Operative, Post - Operative - 6 weeks<br>6 months, 12 months, 24 months];NZ iDXA/Anato stem substudy primary outcome: To compare the % differences in pre-operative (BMD) over time, in the regions of interest (ROIs) based on the Gruen zones, around the Accolade II, Corail or Anato stems. This percent change in BMD will be measured using an iDXA machine.[Pre-op, 6 week, 12 mnth, 24 mth]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath